BillionToOne Appoints Dr. Allen Chen to Lead Northstar Oncology, Palmer Becomes Emeritus
BillionToOne appointed Dr. Allen Chen, MD, MBA, as VP of Medical Affairs and Clinical Development, Oncology to steer Northstar liquid biopsy strategy, drawing on his 20+ years at UC Davis, UCLA and other leading centers. Retiring CMO Gary Palmer transitions to CMO Emeritus to advise on oncology growth.
1. Dr. Allen Chen Joins as VP of Medical Affairs and Clinical Development, Oncology
Allen Chen, MD, MBA, FASTRO, FACHE, brings over two decades of experience from academic centers including UC Davis, UCLA and UC Irvine to lead BillionToOne’s Northstar oncology medical strategy and translational research. In his role, he will oversee clinical development for Northstar Select® and Northstar Response® liquid biopsy assays, aiming to expand actionable genomic testing and real-time tumor monitoring.
2. Dr. Gary Palmer Transitions to CMO Emeritus Advisory Role
After establishing BillionToOne’s oncology clinical strategy and shaping the Northstar portfolio, Dr. Gary Palmer retires as Chief Medical Officer, Oncology but will continue advising the company in a CMO Emeritus capacity. His ongoing input is expected to guide clinical trial design and commercialization efforts as the oncology business scales.